Table 2.

Characteristics of patients with atypia that elected to use or not use tamoxifen

Women with atypia on RPFNA, Masood >15 (n = 18)Elected to use tamoxifen (n = 9)Elected not to use tamoxifen (n = 9)
Average age in years (range)46 (39-56)43 (33-50)
Race
    Caucasian5 (56%)9 (100%)
    African American4 (44%)0 (0%)
    Ashkenazi Jewish0 (0%)0 (0%)
Median Gail score (range)2.8 (1.3-5.4)2.5 (0.9-12.9)
    Subjects eligible for Gail risk assessment4/9 (44%)7/9 (78%)
Menopausal status
    Postmenopausal1 (11%)1 (11%)
    Pre/Perimenopausal8 (89%)8 (89%)
Hormone replacement use
    Current0 (0%)1 (11%)
    Ever0 (0%)0 (0%)
    Never9 (100%)8 (89%)
Oral contraceptive use
    5 y or greater4 (44%)5 (56%)
    1-5 y4 (44%)3 (33%)
    Never1 (11%)1 (11%)
Prior abnormal biopsies
    Lobular carcinoma in situ1 (11%)0 (0%)
    Ductal carcinoma in situ2 (22%)1 (11%)
    Atypical ductal hyperplasia2 (22%)2 (22%)
    No abnormalities4 (44%)6 (67%)